Guillain Barré syndrome and COVID-19: Possible role of the cytokine storm

Autoimmun Rev. 2020 Dec;19(12):102681. doi: 10.1016/j.autrev.2020.102681. Epub 2020 Oct 22.

Authors

Faraz S Hussain¹, Mohamed A Eldeeb², Derrick Blackmore¹, Zaeem A Siddiqi³

Affiliations

¹ Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
² Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada. Electronic address: eldeeb@ualberta.ca.
³ Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Electronic address: zsiddiqi@ualberta.ca.

No abstract available

Publication types

Letter

MeSH terms

Animals
COVID-19 / complications*
COVID-19 / immunology
COVID-19 Drug Treatment
Cytokine Release Syndrome / complications*
Cytokine Release Syndrome / drug therapy
Cytokine Release Syndrome / immunology
Guillain-Barre Syndrome / drug therapy
Guillain-Barre Syndrome / etiology*
Guillain-Barre Syndrome / immunology
Guillain-Barre Syndrome / physiopathology
Humans
Mice
Pandemics
SARS-CoV-2 / pathogenicity